İ. DOĞAN Et Al. , "Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors," Eurasian Journal of Pulmonology , vol.25, no.1, pp.27-32, 2023
DOĞAN, İ. Et Al. 2023. Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors. Eurasian Journal of Pulmonology , vol.25, no.1 , 27-32.
DOĞAN, İ., KHANMAMMADOV, N., PAKSOY, N., VATANSEVER, S., SAİP, P., & AYDINER, A., (2023). Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors. Eurasian Journal of Pulmonology , vol.25, no.1, 27-32.
DOĞAN, İzzet Et Al. "Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors," Eurasian Journal of Pulmonology , vol.25, no.1, 27-32, 2023
DOĞAN, İzzet Et Al. "Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors." Eurasian Journal of Pulmonology , vol.25, no.1, pp.27-32, 2023
DOĞAN, İ. Et Al. (2023) . "Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors." Eurasian Journal of Pulmonology , vol.25, no.1, pp.27-32.
@article{article, author={İzzet DOĞAN Et Al. }, title={Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors}, journal={Eurasian Journal of Pulmonology}, year=2023, pages={27-32} }